What is the name of the histological classification of membranous nephropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Histological Classification of Membranous Nephropathy

The International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification is the standard histological classification system for membranous nephropathy, characterized primarily by subepithelial immune complex deposits. 1

Key Histological Features

Primary Diagnostic Finding

  • Subepithelial immune deposits: The pathognomonic finding of membranous nephropathy
    • Located between podocytes and the glomerular basement membrane
    • Appear as granular, electron-dense, unorganized structures on electron microscopy 2
    • Often contain antibodies against phospholipase A2 receptor (PLA2R) in primary membranous nephropathy 2

Stages of Membranous Nephropathy (Ehrenreich-Churg Classification)

The histological staging is based on the location and appearance of immune deposits and basement membrane changes:

  1. Stage I: Subepithelial deposits without GBM thickening
  2. Stage II: Deposits with projections of basement membrane material between deposits
  3. Stage III: Deposits completely surrounded by basement membrane material
  4. Stage IV: Deposits with incorporation into thickened, irregular basement membrane with lucent areas 3

Immunofluorescence Findings

  • Granular capillary wall deposits of IgG (predominant)
  • Often with C3 complement deposition
  • May have kappa and lambda light chains with similar intensity 1

Clinical-Pathological Correlations

Prognostic Significance

  • Higher histological stages (III-IV) are associated with increased risk of progression to end-stage renal failure (hazard ratio 5.3) 3
  • The presence of tubulointerstitial lesions, vascular sclerosis, and secondary focal segmental glomerulosclerosis correlates with poorer renal outcomes 4
  • However, these histologic features are not independent predictors of outcome when controlling for baseline clinical variables (age, blood pressure, creatinine clearance) 4

Membranous Nephropathy in Lupus Nephritis

  • Classified as Class V in the ISN/RPS classification for lupus nephritis 1
  • When combined with proliferative lesions (Class III or IV), should be treated as Class III or IV 1
  • Pure membranous lupus nephropathy (Class V alone) may be approached differently from proliferative forms 1, 5

Differential Diagnosis Based on Histology

  • Immune-complex GN: Different pattern of deposits (mesangial, subendothelial) 1
  • Proliferative GN: Shows diffuse endocapillary proliferation not typical of membranous nephropathy 2
  • IgA nephropathy: Characterized by mesangial IgA deposits rather than subepithelial deposits 2
  • C3 glomerulopathy: Dominant C3 with minimal or no immunoglobulin deposits 1
  • Monoclonal gammopathy-associated membranous pattern: May show restriction to a single light chain type 1

Clinical Implications of Histological Classification

  • Histological classification guides therapeutic decisions:

    • Class V membranous nephropathy with nephrotic-range proteinuria (>3.5g/day) warrants immunosuppressive therapy 1
    • Non-nephrotic proteinuria may be managed with conservative therapy including RAS blockade 6, 7
    • The presence of proliferative features requires more aggressive immunosuppression 1
  • The extent and characteristics of deposits may correlate with treatment response and long-term prognosis 2

The ISN/RPS classification system provides a standardized approach to the histological evaluation of membranous nephropathy, facilitating appropriate treatment decisions and prognostication based on morphological features.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nephrotic Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prediction in idiopathic membranous nephropathy.

Kidney international, 1999

Research

Glomerular diseases: membranous nephropathy--a modern view.

Clinical journal of the American Society of Nephrology : CJASN, 2014

Research

Novel Treatments Paradigms: Membranous Nephropathy.

Kidney international reports, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.